PERCEPTIVE ADVISORS LLC Makes Strategic Move with Acquisition of X4 Pharmaceuticals Shares

Perceptive Advisors LLC acquired 6.06 million shares of X4 Pharmaceuticals at $3.74 per share, representing a 0.83% impact on its portfolio. The firm's investment strategy focuses on innovative healthcare companies, and the acquisition aligns with this philosophy. X4 Pharmaceuticals faces financial challenges but has a promising pipeline for rare diseases. The investment reflects Perceptive Advisors' confidence in the company's potential for long-term success.